XML 90 R77.htm IDEA: XBRL DOCUMENT v3.24.1
Note 16 - Stock Option and Purchase Plans (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant 2,376,021 2,895,771
Share-Based Payment Arrangement, Expense $ 813,000 $ 683,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value $ 1.26 $ 1.67
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period 525,600 138,900
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value $ 312,000 $ 176,000
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $ 1,111,000  
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 3 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value $ 268,000 285,000
The 2015 Omnibus Plan [Member]    
Share Based Compensation Arrangement By Share Based Payment Award Award Lapsing Restrictions Period 3 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period 5 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period 3 years  
Share-Based Payment Arrangement, Option [Member] | The 2015 Omnibus Plan [Member]    
Common Stock, Capital Shares Reserved for Future Issuance 3,476,021  
Share-Based Payment Arrangement, Option [Member] | The 2020 Omnibus Plan [Member]    
Common Stock, Capital Shares Reserved for Future Issuance 4,596,271  
Restricted Stock [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 0 $ 0